Clinical Trial

Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly

Study acronym: DARE
Recruiting
View on ClinicalTrials.gov →
Summary
The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services. The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.
Trial Details
NCT Number NCT07504965
Lead Sponsor Ludwig-Maximilians - University of Munich
Collaborators: Bayerisches Staatsministerium für Gesundheit, Pflege und Prävention
Conditions Mild Cognitive Impairment, Mild Dementia
Enrollment 1,020 participants
Start Date 2025-07-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-01